Company: IONQ
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0000950170-25-059289
Chunk: 23

Company: IonQ, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 23
---
 election to our board of directors;

reviewing our succession planning process for our executive officers;

overseeing our board of directors’ committee structure and operations;

reviewing and making recommendations to our board of directors regarding our corporate governance guidelines and corporate governance framework;

overseeing the evaluation of the performance of our board of directors and its committees; and

making recommendations to our board of directors regarding processes for stockholder communications with the non-management members of our board of directors.

Our nominating and corporate governance committee operates under a written charter that satisfies the applicable listing standards of the NYSE. A copy of the charter of our nominating and corporate governance committee is available on our website atinvestors.ionq.com. During 2024, our nominating and corporate governance committee held nine meetings.

Attendance at Board and Stockholder Meetings

During our fiscal year ended December 31, 2024, our board of directors held nine meetings (including regularly scheduled and special meetings), and each director attended at least 75% of the aggregate of (1) the total number of meetings of the board of directors held during the period for which he or she has been a director and (2) the total number of meetings held by all committees on which he or she served during the periods that he or she served.

Although we do not have a formal policy regarding attendance by members of our board of directors at the annual meetings of stockholders, we encourage, but do not require, directors to attend. All of our directors attended our 2024 annual meeting of stockholders, who were directors at the time.

ExecutiveSessions of Non-Employee Directors

To encourage and enhance communication among non-employee directors, and as required under applicable NYSE rules, our corporate governance guidelines provide that our non-employee independent directors will meet in executive sessions with the lead independent director presiding and without management present on a periodic basis.

<div align='center'>-13-</div>

Compensation Committee Interlocks and Insider Participation

The current members of our compensation committee are Ms. Chou and Mr. Scannell. Mr. Scannell was appointed to the compensation committee on July 23, 2024. Craig Barratt was a member of the compensation committee until the expiration of his term on the board of directors, effective June 5, 2024. Harry You was a member of the compensation committee until his resignation from the board of directors, effective February 26, 2025. None of the members of our compensation committee, or anyone who served as a member